[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"melanoma-stage\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:melanoma-stage":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100565523","evaluation-of-a-personalised-survivorship-care-plan-app-for-patients-with-melanoma-100565523",false,"NCT06643286","Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma","Personalised Survivorship Care for Patients With Melanoma: A Multicenter Randomised Controlled Trial of the Survivorship Care Plan App","Melanoma SCP","Inclusion Criteria:\n\n* 18 years or older\n* Patients who have received a primary diagnosis of cutaneous melanoma stage I to II in the past 0-4 months\n\nExclusion Criteria:\n\n* Patients with irresectable stage III melanoma, patients receiving neo-adjuvant treatment and patients with stage IV melanoma.\n* Patients who do not have (sufficient) command of the Dutch language.","ALL","18 Years",{"count":20,"type":21},180,"ESTIMATED","INTERVENTIONAL",[24],"NA","A multicentre randomised controlled trial (RCT) will be conducted to evaluate the effectiveness of the digital personalised Melanoma Survivorship Care Plan (SCP) app. A total of hundred-eighty melanoma patients (stage I and II) will be randomised to receive either the SCP Melanoma app or usual care. The app provides survivors with personalized healthcare information on diagnosis, treatment and follow-up and supportive care, tailored to their melanoma stage and phase and information needs.Through questionnaires, medical file records, patient-reported outcomes and use of medical care will be evaluated. In addition, log-data, questionnaires and interviews will be used to evaluate the process of the uptake and implementation of the digital SCP.",[27,28,29,30],"Melanoma (Skin)","Melanoma, Stage II, Stage I","Melanoma Stage","Survivorship",[32,33,34],"Survivorship care","Application","RCT","RECRUITING","2025-06-06",{"date":38,"type":39},"2025-06-11","ACTUAL",{"date":41,"type":39},"2025-04-01",{"date":43,"type":21},"2026-12-01",{"name":45,"class":46},"Erasmus Medical Center","OTHER",4]